|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
421.800 -7.800 (-1.816%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 950,445 | -31.266% | 1,933,045 | 1,540,493 | 803,933 | 32,322 |
| Cost of Sales | (290,457) | -5.111% | (659,388) | (781,308) | (276,828) | (20,525) |
| Gross Profit | 659,988 | -38.702% | 1,273,657 | 759,185 | 527,105 | 11,797 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (175,555) | -- | (142,545) | (467,692) | (567,364) | (889,795) | |
| Taxation | 30,380 | -- | (124,221) | (106,442) | (48,735) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (145,175) | -- | (266,766) | (574,134) | (616,099) | (889,795) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 3,022 | 20.542% | (30,381) | 39,123 | 147,397 | 111,785 |
| Depreciation & Amortisation | -- | -- | 91,386 | 75,076 | 67,364 | 22,914 |
| Directors' Emoluments | -- | -- | 32,162 | 22,574 | 7,942 | 13,106 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -64.000 | -- | -120.000 | -284.000 | -574.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (1.939) | 0.324 | (2.836) | -- |
| NBV per share ($) | 21.503 | -- | 14.558 | 10.627 | -- | -- |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -145,175 |
| %Change | -- |
| EPS / (LPS) | RMB -0.640 |
| NBV Per Share (¥) | RMB 21.503 |